Premium
Evaluation of vitamin D levels in allergic fungal sinusitis, chronic rhinosinusitis, and chronic rhinosinusitis with polyposis
Author(s) -
Mostafa Badr ElDin,
Taha Mohammed Shehata,
Abdel Hamid Tarek,
Omran Azza,
Lotfi Neema
Publication year - 2016
Publication title -
international forum of allergy and rhinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.503
H-Index - 46
eISSN - 2042-6984
pISSN - 2042-6976
DOI - 10.1002/alr.21585
Subject(s) - medicine , chronic rhinosinusitis , sinusitis , chronic sinusitis , dermatology , nasal polyps , immunology
Background Vitamin D 3 (VD 3 ) levels have been recently found to be responsible for a number of immunological, anti‐inflammatory and anti‐infectious roles. Some studies reported that some forms of allergic fungal rhinosinusitis (AFRS), occurs more commonly in patients who are more susceptible to VD 3 deficiency. The aim of this work was to measure VD 3 levels in patients with AFRS and chronic rhinosinusitis (CRS). Methods We report a prospective case control study conducted at Ain Shams University. It included 74 participants divided into 4 groups: group A, 25 patients with AFRS; group B, 15 patients with CRS with nasal polyps (CRSwNP); group C: 15 patients with CRS without nasal polyps (CRSsNP); and group D, 19 controls. Results There was a statistically significant ( p < 0.001) difference of VD 3 between groups A and B compared with groups C and D. There were no statistically significant differences between the 4 groups regard calcium levels. Finally, there was a statistically significant difference in phosphate levels when we compared groups A and B with groups C and D ( p = 0.001). Conclusion Serum level of VD 3 in patient with CRSwNP and AFRS is significantly lower than that of patients with CRSsNP and control subjects. Although these results do not imply a specific etiological or therapeutic relationship, VD 3 levels may constitute an inexpensive prophylactic and cost‐effective option in the therapeutic armamentarium in the control of AFRS and CRSwNP, either by itself or as a synergistic agent with traditional agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom